Alzheimer Disease Clinical Trial
Official title:
Phase 1 a One Year Study of Using Hypnotherapy to Control Beta-amyloid Buildup That Causes Alzheimer's & Dementia CANCELLED
From the past research that has been done the investigators have learned that brain cells
die & leave a deposit in the brain known as beta-amyloid. Since alzheimer's is a slow acting
disease the natural immune system does not respond to this illness so this builds up in the
brain. As it builds up it gets into the neurotransmitters in the brain causing more brain
cells to die. As these buildups occur dementia sets in due to more of the brain dying &
effects normal activity.
STUDY WAS CANCELLED
Hypnotherapy will be used to do the following things:
- Increase the immune system
- The immune system will begin to clean up the beta-amyloid buildup
- That removes damage cells of the brain
- Increase more blood flow to the brain
- Allows the active brain cells to be trained to carry out daily activities
STUDY WAS CANCELLED
Hypnotherapy has been used for many things through the years. Today many doctors use it for
their patients for operations when blood supply is low to control bleeding, pain for
difficult dental work, mental issues & many other things.
Back in the 1950's a doctor Wilhelm Reich was able to increase the immune system & tested it
by blood samples. The immune system isn't sending enough white blood cells into the brain to
clean up beta-amyloids. Using hypnotherapy could increase the white blood cells to the brain
to clean up the damage.
In theory the primitive part of the brain ( 1%)job is to protect the body from harm. It does
this by giving out a fight or flight response to the subconscious mind which is (88%) of our
brain. Then the conscious mind controls the body to either fight or flight. Since
Alzheimer's is such a slow moving disease the primitive part of the brain does not react
because of the slow action. So the subconscious never gets the message that there's a
disease in the brain so the body could fight it off.
As the immune system cleans up the beta-amyloid buildup the healthy neurotransmitters are
able to function. Healthy brain cells can be retrained so the quality of life can be more
normal.
EXAMPLE:
* If you imagine driving down the same path across a field day after day. Before to long the
grass dies & ruts start to form. Next thing you know your auto is hitting high center. So
you have to move over to keep from getting stuck in the ruts. The brain works in the same
way. The person do things without thinking because that is how the brain has been trained.
But the brain can be retrained to do the functions as it did before the illness.
Hypnotherapy session will be:
- One hour long
- one session per month for 9 months
- 3 months free of any sessions to measure the effect
STUDY WAS CANCELLED
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |